CMR myocardial tissue characterization in a mouse model of doxorubicin-induced cardiotoxicity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1532-429X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
CMR myocardial tissue characterization in a mouse model of doxorubicin-induced cardiotoxicity ; volume:17 ; number:1 ; day:3 ; month:2 ; year:2015 ; pages:1-3 ; date:12.2015
Journal of cardiovascular magnetic resonance ; 17, Heft 1 (3.2.2015), 1-3, 12.2015
- Creator
-
Allen, Bradley D.
- Contributor
-
Anderle, Micah
Misener, Sol
Murtagh, Gillian
Furiasse, Nicholas
Akhter, Nausheen
Procissi, Daniele
Carr, James C.
SpringerLink (Online service)
- DOI
-
10.1186/1532-429X-17-S1-Q135
- URN
-
urn:nbn:de:1111-2016032322928
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Allen, Bradley D.
- Anderle, Micah
- Misener, Sol
- Murtagh, Gillian
- Furiasse, Nicholas
- Akhter, Nausheen
- Procissi, Daniele
- Carr, James C.
- SpringerLink (Online service)
Other Objects (12)
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Empagliflozin prevents doxorubicin-induced myocardial dysfunction
Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α
Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Empagliflozin prevents doxorubicin-induced myocardial dysfunction
Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α
Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Empagliflozin prevents doxorubicin-induced myocardial dysfunction
Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α
Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity